BIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement

• Post author:GHIAA Admin
• Post published:March 3, 2023
• Post category:

Continue ReadingBIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement

CEPI CfP3i Template Funding Agreement

• Post author:GHIAA Admin
• Post published:January 17, 2023
• Post category:

Continue ReadingCEPI CfP3i Template Funding Agreement

CEPI – Novavax, COVID-19 Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:January 10, 2023
• Post category:

Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement

CEPI – VBI, COVID-19 Vaccine Development Funding Agreement

• Post author:GHIAA Admin
• Post published:December 12, 2022
• Post category:

Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement

FIND Sample Funding Terms and Conditions

• Post author:GHIAA Admin
• Post published:December 7, 2022
• Post category:

Continue ReadingFIND Sample Funding Terms and Conditions

UnitaidExplore Sample Funding Terms and Conditions

• Post author:GHIAA Admin
• Post published:December 1, 2022
• Post category:

Continue ReadingUnitaidExplore Sample Funding Terms and Conditions

Gates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement

• Post author:GHIAA Admin
• Post published:November 8, 2022
• Post category:

Continue ReadingGates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement

Drugs For Neglected Diseases Initiative – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement

• Post author:GHIAA Admin
• Post published:October 26, 2022
• Post category:

Continue ReadingDrugs For Neglected Diseases Initiative – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement

Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement

• Post author:GHIAA Admin
• Post published:September 28, 2022
• Post category:

Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement